Immunosuppressive Agents: all 5,940 studies that test it
Page 38 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Simulect Versus ATG in Sensitized Renal Transplant PatientCompletedNCT02377193Phase 4
- A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)CompletedNCT02376049Phase 1
- Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's SyndromeStatus unknownNCT02370550Phase 4
- The Effect of Locally Delivered Ciclosporin as an Adjunct to Healing After Treatment of Periodontal PocketsCompletedNCT02366585Phase 2
- A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese SubjectsCompletedNCT02365948Phase 1
- Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast CancerCompletedNCT02365805Phase 2
- Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent PlacementWithdrawnNCT02365415Phase 2
- Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion ProteinCompletedNCT02364479Phase 4
- CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple MyelomaStatus unknownNCT02362165Phase 3
- A Study of SGT-53 in Children With Refractory or Recurrent Solid TumorsSuspendedNCT02354547Phase 1
- Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast CancerCompletedNCT02344550Phase 2
- Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia MajorCompletedNCT02342145Phase 4
- Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male VolunteeersCompletedNCT02341274Phase 1
- Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in ChildrenStatus unknownNCT02339350Phase 2
- Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE)TerminatedNCT02338570Phase 4
- Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT02337426Phase 1
- Pharmacokinetic of Tacrolimus in Paediatric Liver Transplant PatientsStatus unknownNCT02337036Not applicable
- Combination of Everolimus and Octreotide LAR in Aggressive Recurrent MeningiomasCompletedNCT02333565Phase 2
- Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell TransplantSuspendedNCT02333162Phase 1
- Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AIONStatus unknownNCT02329288Phase 3
- Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine ACompletedNCT02328963Phase 4
- 25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in ChinaStatus unknownNCT02328118Phase 2/3
- Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to GilenyaStatus unknownNCT02325440Phase 4
- Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell LymphomasTerminatedNCT02323659Phase 4
- A Study of DPX-Survivac Vaccine Therapy in Patients With Recurrent Survivin-expressing DLBCLTerminatedNCT02323230Phase 2
- Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung CancerActive, not recruitingNCT02321501Phase 1
- Efficacy and Safety of Everolimus in de Novo Kidney Transplant Recipients of ECD or AKI DonorsStatus unknownNCT02314312Phase 3
- Topical Steroids Alone or Associated With Methotrexate in Bullous PemphigoidCompletedNCT02313870Phase 3
- Maintenance Treatment Versus Observation in Elderly Patients With PCNS LymphomaStatus unknownNCT02313389Phase 3
- Everolimus trIal for Advanced prememopausaL Breast Cancer PatientsStatus unknownNCT02313051Phase 2
- Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic PolymorphismStatus unknownNCT02311010Phase 4
- Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular EdemaCompletedNCT02310295Not applicable
- A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With EverolimusCompletedNCT02305810Phase 2
- Retreatment and Its Efficiency of Thalidomide for Vascular Malformation Patients With Failure of First Course TreatmentWithdrawnNCT02301949Phase 2
- Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory NeuroblastomaActive, not recruitingNCT02298348Phase 1
- Bioavailability Study of Sirolimus Tablets 2 mg Under Fed ConditionCompletedNCT02296762Phase 1
- Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting ConditionCompletedNCT02296749Phase 1
- An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability DeflazacortCompletedNCT02295748Phase 1
- Ketorolac Versus Triamcinolone Knee Injections for OsteoarthritisCompletedNCT02295189Not applicable
- Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCTCompletedNCT02294552Phase 2
- RICE: Remission by Intra-articular Injection Plus CErtolizumabCompletedNCT02293590Phase 2
- Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of DeflazacortCompletedNCT02286635Phase 1
- A Single Dose Evaluation of the Effects of Renal Impairment on Deflazacort PharmacokineticsCompletedNCT02286622Phase 1
- A Single Dose Evaluation of the Effects of Moderate Hepatic Impairment on Deflazacort PharmacokineticsCompletedNCT02286609Phase 1
- Synergetic B-cell Immodulation in SLECompletedNCT02284984Phase 2
- Thiopurine Induced Pancreatitis in IBD PatientsWithdrawnNCT02281799Phase 4
- Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy SubjectsCompletedNCT02281370Phase 1
- Open-label Pilot Study of Abatacept for the Treatment of VitiligoStatus unknownNCT02281058Phase 1
- Low Dose Metronomic Poly-chemotherapy for Metastatic CRCCompletedNCT02280694Phase 2
- Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic MelanomaCompletedNCT02278887Phase 3
- HER2-Peptide Vaccination of Patients With Solid TumorsCompletedNCT02276300Phase 1
- Infusion of Allogeneic, 3rd Party CD19-specific T CellsWithdrawnNCT02274506Phase 1
- Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal CancerCompletedNCT02271464Phase 2
- Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding PolypharmacyStatus unknownNCT02270970Phase 4
- MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) ProphylaxisStatus unknownNCT02270307Phase 2/3
- Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose EscalationCompletedNCT02269358Phase 4
- A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus CapsuleTerminatedNCT02268201Phase 4
- Safety and Efficacy of Etanercept in Patients With PsoriasisStatus unknownNCT02258282Not applicable
- A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic SyndromeCompletedNCT02257697Phase 3
- A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus NephritisCompletedNCT02256150Phase 3
- Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin LymphomaTerminatedNCT02254239Phase 1
- Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal TransplantStatus unknownNCT02251691Phase 4
- A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular DystrophyCompletedNCT02251600Phase 1
- Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic SyndromeActive, not recruitingNCT02250937Phase 2
- Quality of Life of Patients With Psoriasis Treated With Methotrexate: Prospective, Randomized, Double-blind, Parallel Group Study.Status unknownNCT02248792Phase 4
- Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With BevacizumabCompletedNCT02248571Phase 4
- Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3)CompletedNCT02248012Phase 2
- Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence.TerminatedNCT02247258Phase 2
- Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic CancerCompletedNCT02240719Phase 1
- Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) EradicationStatus unknownNCT02233049Phase 2
- Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye DiseaseCompletedNCT02229955Phase 3
- Photophoresis Versus Ciclosporine in Severe Atopic DermatitisCompletedNCT02226068Not applicable
- Cyclosporine A in Patients With Small Diameter Abdominal Aortic AneurysmsStatus unknownNCT02225756Phase 2
- Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve GastrectomyCompletedNCT02221583Phase 4
- Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone AcetonideCompletedNCT02221453Phase 2
- A First-In-Human Study With a Single Dose UCB7665 in Healthy VolunteersCompletedNCT02220153Phase 1
- Carfilzomib, Cyclophosphamide, Dexamethasone in Transplant Eligible Newly Diagnosed High-risk Multiple MyelomaCompletedNCT02217163Phase 2
- Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast CancerWithdrawnNCT02215876Phase 2
- Treatment of Port Wine Stains Using Pulsed Dye Laser, Erbium Yag Laser and Topical SirolimusTerminatedNCT02214706Not applicable
- Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic SyndromeCompletedNCT02212561Phase 1
- Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney TransplantStatus unknownNCT02208791Phase 4
- Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)CompletedNCT02206503Phase 2
- Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma PatientsCompletedNCT02206425Phase 1/2
- LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell HistiocytosisActive, not recruitingNCT02205762Phase 2/3
- An Open Label, Single-Centre, Pilot Study of Everolimus With EBRT for the Treatment of mNET Liver MetastasisCompletedNCT02205515Phase 1/2
- Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma PatientsCompletedNCT02204241Phase 1/2
- Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.CompletedNCT02203643Phase 2
- A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic AnemiaCompletedNCT02203396Phase 2
- Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and VomitingCompletedNCT02203253Phase 3
- Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing SpondylitisCompletedNCT02201043Phase 2
- Autologous ROR1R-CAR-T Cells for Chronic Lymphocytic Leukemia (CLL)WithdrawnNCT02194374Phase 1
- Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal CancerCompletedNCT02188264Phase 1
- Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With GolimumabStatus unknownNCT02186886Phase 4
- Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast CancerTerminatedNCT02183805Phase 2
- Intra-Osseous Co-Transplant of UCB and hMSCCompletedNCT02181478Early Phase 1
- Sirolimus Prophylaxis for aGVHD in TME SCIDWithdrawnNCT02177760Phase 2
- A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination TherapyCompletedNCT02177071Phase 4
- Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk NeuroblastomaActive, not recruitingNCT02176967Phase 3
- Trial of Cyclosporine in the Acute Phase of Leber Hereditary Optic NeuropathyStatus unknownNCT02176733Phase 2
- Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple MyelomaCompletedNCT02176213Phase 2